VZV vaccination to prevent herpes zoster after transplantation

Registry ID

EUCTR2009-014268-20

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE4

Sponsor

Erasmus MC

Start date

2009-07-28

Last update

2026-08-16

Conditions

• Herpes Zoster

Summary

To study if there is a role for prophylactic VZV vaccination prior to transplantation to boost the patients B- and T-cell repertoire and thereby reducing the incidence and morbidity associated with herpes zoster.

Locations

• , , Netherlands

Related clinical trials

• Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
• Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine
• A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland
• The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster
• The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
• A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

View on source registry